{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Interferon‐α8 (IFNA8) is emerging as an important type I interferon subtype with pleiotropic roles in innate immunity, antiviral defense, and immunoregulation. Genetic studies in malaria‐endemic populations have demonstrated that specific promoter polymorphisms in IFNA8 are associated with reduced circulating IFN‐α levels and increased susceptibility to severe malarial anemia, whereas other IFNA8 variants may exert protective effects in regions with lower malaria endemicity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In the context of viral infections, differential induction of IFNA subtypes has been observed; overexpression of interferon regulatory factor‐5 preferentially stimulates IFNA8 expression—as opposed to IFNA1—suggesting that IFNA8 transcription is subject to a virus‐ and cell type–specific regulation via distinct IRF pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, robust methods for recombinant expression in both yeast and bacteria have been established, yielding properly folded IFNA8 with demonstrable antiviral and anti‐proliferative activities; in fact, IFNA8 exhibits higher potency than IFNAα2b in antiviral assays."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Distinct pharmacokinetic properties have been reported as well, with IFNA8 displaying enhanced vascular permeability and stability compared to other subtypes, findings that were further supported by the development of a highly sensitive IFNA8‐specific ELISA."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In addition, molecular engineering to generate IFNA8 mutants has revealed that modifications affecting surface charge can prolong receptor–ligand dissociation times without altering overall binding affinity, thereby enhancing the downstream antiviral and antiproliferative effects."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Preclinical evaluations of an IFNA8 fusion protein have demonstrated a potency approximately 10‐fold greater than that of pegylated IFNAα2a, suggesting that IFNA8‐based therapeutics may offer improved dosing regimens and efficacy in the treatment of chronic viral infections."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Altered IFNA8 mRNA expression has also been observed in the setting of inflammatory disorders such as pulmonary embolism and in lesions associated with human papillomavirus infection, implicating IFNA8 in the modulation of immune responses during pathologic conditions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " Finally, population genetic analyses indicate that the IFNA8 gene is overwhelmingly represented by the IFNA8b allele in large donor cohorts, while alternative allelic forms appear exceedingly rare, and rare somatic mutations in IFNA8 have been detected in tumor sequencing studies with yet unclear functional consequences."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Prakasha Kempaiah, Samuel B Anyona, Evans Raballah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-012-1175-1"}], "href": "https://doi.org/10.1007/s00439-012-1175-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22570109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22570109"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kanika Kanchan, Pankaj Jha, Sudhanshu S Pati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interferon-γ (IFNG) microsatellite repeat and single nucleotide polymorphism haplotypes of IFN-α receptor (IFNAR1) associated with enhanced malaria susceptibility in Indian populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Infect Genet Evol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.meegid.2014.10.030"}], "href": "https://doi.org/10.1016/j.meegid.2014.10.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25445652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25445652"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "B J Barnes, P A Moore, P M Pitha "}, {"type": "b", "children": [{"type": "t", "text": "Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M101216200"}], "href": "https://doi.org/10.1074/jbc.M101216200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11303025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11303025"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "S Di Marco, G Fendrich, B Meyhack, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Refolding, isolation and characterization of crystallizable human interferon-alpha 8 expression in Saccharomyces cerevisiae."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biotechnol (1996)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/0168-1656(96)01550-7"}], "href": "https://doi.org/10.1016/0168-1656(96"}, {"type": "t", "text": "01550-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "8987847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/8987847"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Julio César Sánchez García, Alejandro Miranda Ariza, Alexis Musacchio Lasa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased antiviral activity of microscale-purified HuIFN alpha 8 (human interferon alpha 8) over HuIFN alpha 2b in Hep-2 cells challenged with Mengo virus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biotechnol Appl Biochem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BA20060211"}], "href": "https://doi.org/10.1042/BA20060211"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17523917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17523917"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Chie Ushio, Harumi Ariyasu, Tohru Kayano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Establishment of antihuman IFN-alpha8-specific monoclonal antibodies and their application in the enzyme-linked immunosorbent assay (ELISA)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Interferon Cytokine Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/jir.2007.0121"}], "href": "https://doi.org/10.1089/jir.2007.0121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18593331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18593331"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Kouzo Yamamoto, Madoka Taniai, Kakuji Torigoe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Interferon Cytokine Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/jir.2008.0038"}], "href": "https://doi.org/10.1089/jir.2008.0038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19196068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19196068"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "M Victoria Flores, Timothy P Hickling, Sasha Sreckovic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCV."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Antivir Ther (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3851/IMP2099"}], "href": "https://doi.org/10.3851/IMP2099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22505586"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22505586"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hung Q Doan, Harrison P Nguyen, Peter Rady, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression patterns of immune-associated genes in external genital and perianal warts treated with sinecatechins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Viral Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/vim.2014.0144"}], "href": "https://doi.org/10.1089/vim.2014.0144"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25774455"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25774455"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Wei Lv, Qianglin Duan, Lemin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of B-cell-associated genes in peripheral blood mononuclear cells of patients with symptomatic pulmonary embolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2014.2978"}], "href": "https://doi.org/10.3892/mmr.2014.2978"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25411767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25411767"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Johanna Sandgren, Stefan Holm, Ana Maria Marino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2015/862039"}], "href": "https://doi.org/10.1155/2015/862039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26998479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26998479"}]}]}]}